Expression Negative Control Lentivirus (EF1A Promoter/Hygromycin, Puromycin, or G418)

Only %1 left
Catalog #
82212
As low as $795 *

Cat # Size Price*

Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Expression Negative Control Lentivirus (EF1A Promoter/Hygromycin) are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles ready to transduce nearly all types of mammalian cells, including primary and non-dividing cells. These viral particles do not express a specific protein but include only a geneticin, hygromycin, or puromycin selection marker under the control of the EF1A promoter (Figure 1).

Figure 1. Schematic of the lenti-vector used to generate the Expression Negative Control Lentivirus (EF1A Promoter/G418). This is a SIN vector. 

Figure 1. Schematic of the lenti-vector used to generate the Expression Negative Control Lentivirus (EF1A Promoter/Hygromycin). This is a SIN vector. 

Figure 1. Schematic of the lenti-vector used to generate the Expression Negative Control Lentivirus (EF1A Promoter/Puromycin). This is a SIN vector. 

Product Info
Storage and Usage
Citations
Supplied As
Two vials (500 µl x 2) of lentivirus at a titer ≥107 TU/ml. The titer will vary with each lot; the exact value is provided with each shipment.
Materials Required But Not Supplied
Name Ordering Information
Thaw Medium 1 BPS Bioscience #60187
Firefly Luciferase Lentivirus (EF1A Promoter/Geneticin, Hygromycin, or Puromycin) BPS Bioscience #78740
Lenti-Fuse™ Polybrene Viral Transduction Enhancer BPS Bioscience #78939
96-well tissue culture-treated assay plates  
ONE-Step™ Luciferase Assay System BPS Bioscience #60690
Formulation

The lentivirus particles were produced in HEK293T cells in medium containing 90% DMEM + 10% FBS. Virus particles can be packaged in custom formulations by special request, for an additional fee.

Background

The use of antibiotics in cell culture as a method to establish stable cell lines by imposing selective pressure on cells expressing the antibiotic resistance, is a common practice. However, the use of antibiotics can result in altered gene expression and regulation. For instance, analysis of the impact of the use of penicillin-streptomycin has identified 209 penicillin-streptomycin specific genes, including transcription factors. In view of these findings, care should be taken when performing genetic, genomic and biological studies in cells treated with antibiotics. In those cases, the use of a control where only the antibiotic resistance is expressed can prove valuable in assessing the specificity of the cellular response to the expression of a protein of interest

References

Ryu A., et al., 2017 Scientific Reports 7:7533